Background: The gene expression profile of a tissue averages the expression profiles of all cells in this tissue. Digital tissue deconvolution (DTD) addresses the following inverse problem: Given the expression profile y of a tissue, what is the cellular composition c of that tissue? If X is a matrix whose columns are reference profiles of individual cell types, the composition c can be computed by minimizing L(y − Xc) for a given loss function L. Current methods use predefined all-purpose loss functions. They successfully quantify the dominating cells of a tissue, while often falling short in detecting small cell populations.
Introduction
Different tissues of the body have different cellular compositions. The composition of tumor tissue is different from that of normal tissue. Also, when comparing two tumor tissues, their cellular composition can differ greatly. The relatively small populations of tumor-infiltrating immune cells are of particular importance. They affect progression of disease (Galon et al., 2006) and success of treatment (Fridman et al., 2012) . Immune therapies block communication lines between tumor cells and infiltrating immune cells. Whether they are successful or not depends on the presence, quantity, and molecular sub-type of the infiltrating immune cells (Hackl et al., 2016) . Immune-cell populations are typically small, and their molecular phenotype can be difficult to observe under the microscope. Single-cell technologies such as fluorescence-activated cell sorting (FACS; Ibrahim and van den Engh (2007) ), cytometry by time-of-flight (CyTOF; e.g. Bendall et al. (2011)) , and single-cell RNA sequencing (Wu et al., 2014) assess molecular features on the single-cell level and can thus be used to determine the cellular tissue composition experimentally.
A more cost-and work-efficient alternative to single-cell assays is a combination of bulk-tissue gene expression profiling with digital tissue deconvolution (DTD) (Lu et al., 2003; Abbas et al., 2009; Gong et al., 2011; Qiao et al., 2012; Altboum et al., 2014; Newman et al., 2015; Li et al., 2016) . DTD addresses the following inverse problem: given the bulk gene expression profile y of a tissue, what is the cellular composition c of that tissue? Supervised DTD assumes that there is a matrix X whose columns are reference profiles of individual cell types. The composition c of y can be computed by minimizing L(y − Xc) for a given loss function L. Competing DTD methods use different predefined all-purpose loss functions L and different estimation algorithms to distil c from y and X.
The practical objective of DTD is to estimate c correctly, while the formal objective of common DTD algorithms is to estimate y correctly. If tissue expression profiles were exact mixtures of reference profiles, existing methods should work perfectly. They are not and this causes problems:
(1) Collections of references profiles can be incomplete. There might be cells in the tissue that are not represented by the reference profiles. In that case the global DTD problem is not solvable, and DTD-algorithms will compensate for the contributions of these cells by increasing the frequencies of other cell types.
(2) Small cell fractions are hard to quantify. From a practical point of view this is probably the most important point, and improvements are needed badly. Immunological cell populations in a tumor are small, but they may determine the reaction of a tumor to immunotherapy. Therefore, DTD algorithms must use faint signals from small cell populations more effectively.
(3) Some cell types can hardly be distinguished by their expression profiles. The profile of an epithelial cell differs greatly from that of a lymphoid cell. For two immunological sub-entities of CD8+ T cells the differences are more subtle. The more similar two cell types are, the more similar are their expression profiles, and the more difficult is their distinction.
In summary, different applications need different approaches. One way to adapt the estimation of c is to adapt the loss function L. If the focus of an application is on a predefined set of cell types, genes that are informative to distinguish exactly these cells should dominate L. This is even more important if the focus is on small cell populations, the faint signals of which must not be suppressed. Unfortunately, it is not clear a priori which genes to ignore and which to focus on.
Methods

Notations
Let X ∈ R p×q be a matrix with cellular reference profiles X ·,j in its columns, where the dot stands for all row indices. X ij is the reference expression value of gene i in cells of type j, p the number of genes, and q the number of cell types in X, respectively. We further introduce a matrix Y ∈ R p×n with bulk profiles of n cell mixtures Y ·,k in its columns and a matrix C ∈ R q×n with the cellular compositions of the mixtures C ·,k as columns.
Loss-function learning
Following the established linear DTD algorithms, we approximate the mixture Y ·,k by a linear combination of reference profiles (the columns of X) with C .,k as weights and estimate the composition of the k-th mixture C ·,k by minimizing
where
In contrast to standard DTD algorithms, which determine g by prior knowledge or separate statistical analysis, we will learn g directly from data. To this end we assume that we have a training set of mixtures Y ·,k from a specific application context with known cellular compositions C ·,k . The entries of g are the gene weights that define the loss function. We want to learn g from the training data such that minimizing L g (y − Xc) with respect to c yields accurate quantifications of cell populations for future samples with similar characteristics as those used for training. Our method has two nested objective functions: An outer function L(g) and an inner function L g , which is here given by equation (2). L evaluates discrepancies between the estimated and the true cellular frequencies of cell types across samples:
where theĈ j,· (g) are the estimates of C j,· given g. To evaluate L(g) we need to calculate allĈ j,· (g), which requires optimizing L g with respect to all C ·,k . Note that ifĝ is a minimum of L, so is αĝ.
The constraint ||g|| 2 = 1 is thus needed to ensure unique solutions. The minimum of L g can be calculated analytically, yieldinĝ
with Γ = diag(g). Inserting this term into L leaves us with a single optimization problem in g. We minimize L by a gradient-descent algorithm. Let µ j and σ j be the mean and standard deviation of C j,· , respectively. We obtain the gradient
with
where δ(i) ∈ R p×p is defined as
The constraints ||g|| 2 = 1 and g i ≥ 0 were incorporated by normalizing g by its length and by restricting the search space to g i ≥ 0. 
Results
DTD of melanomas
For both training and validation we need expression profiles of cellular mixtures of known composition. We used expression data of melanomas whose composition has been experimentally resolved using single-cell RNAseq profiling (Tirosh et al., 2016 (52), and tumor/unclassified (1,758). The first 9 melanomas defined our validation cohort and the remaining 10 our training data. First, data were transformed into transcripts per million. Then, for each cell cluster we sampled 20% of single-cell profiles in the training data, summed them up, normalized them to a common number of counts, and removed them from the training data. This yielded reference profiles X ·,j . The 1,000 genes with the highest variance across all reference profiles were used to train models.
The sum of all single-cell profiles of a melanoma gave us bulk profiles. In addition, we generated a large number of artificial bulk profiles by randomly sampling single-cell profiles and summing them up. All bulk profiles were normalized to the same number of reads as those in X ·,j .
Loss-function learning improves DTD accuracy in the case of incomplete reference data
We generated 2,000 artificial cellular mixtures from our training cohort. For each of these mixtures, we randomly drew 100 single-cell profiles, summed up their raw counts, and normalized them to a fixed number of total counts. Analogously, we generated 1,000 artificial cellular validation mixtures. Then, we restricted X to three cell types (T cells, B cells, and macrophages). Hence endothelial cells, CAFs, NK cells and tumor/unclassified cells in the mixtures are not represented in X. For standard DTD with g = (1, . . . , 1), we observed correlation coefficients of 0.70 (T cells), 0.39 (B cells), and 0.52 (macrophages) between true and estimated cell population sizes for the validation mixtures. These improved to 0.86 (T cells), 0.89 (B cells), and 0.83 (macrophages) for loss-function learning, after we ran 1000 iterations of the gradient descent algorithm on the training data.
To test the limits of the approach, we excluded all but the macrophages, which account for less than 3% of all cells, from the reference data X. We observed, that standard DTD broke down, while loss-function learning yielded a model that predicted macrophage abundances that still correlated well (r = 0.84) with the true abundances (Figure 1 ). (a )   IL2RB  KLRF1  S1PR5  CD19  BANK1  MS4A1  CD79A  CD79B  TYROBP  LYZ  IFI30  SPP1  CD68  C1QB  MS4A6A  AIF1  CD14  FCN1  C1QA  FOLR2  VSIG4  MSR1  CSF1R  C3  COL1A1  COL3A1  KRT19  GREM1  CLDN11  FBLN1  C7  MMP1  C1R  MMP2  ADAMTS1  C10orf10  THBS1  CYR61  IGFBP7  SPARCL1  GNG11  ID1  TFPI  VWF  MMRN1  ECSCR  CCL14  CLDN5  EGFL7  HYAL2 NK cells CAFs endo.
macro.
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Loss-function learning improves the quantification of small cell populations
We generated data as above but this time controlling the abundance of B cells in the simulated mixtures at 0 to 5 cells, 5 to 15, 15 to 30, 30 to 50, and 50 to 75 out of 100 cells. Not surprisingly, small fractions of B cells were harder to quantify than large ones. Loss-function learning improved the accuracy for all amounts of B cells, but the improvements were greatest for small amounts ( Figure 2a ). With only 0 to 5 cells in a mixture the accuracy improved from r = 0.22 to r = 0.79. Furthermore, we observed that loss-function learning on small B-cell proportions yielded a model that was highly predictive of B-cell contributions over the whole spectrum (Figure 2a green stars).
If we compare the top-ranked genes of the model learned for the small B-cell population (Figure 2b) to that of the macrophage-focussed simulation (Figure 2c ), we observe that the former still comprises marker genes to distinguish all cell types, while the latter focusses on genes that characterize macrophages.
Loss-function learning improves the distinction of closely related cell types
The cell types that were annotated by Tirosh et al. (2016) displayed very different expression profiles. If we are interested in T-cell subtypes such as CD8+ T cells, CD4+ T-helper (Th) cells, and regulatory T cells (Tregs), reference profiles are more similar and DTD is more challenging. We subdivided the fraction of annotated T-cell profiles as follows: all T cells with positive CD8 (sum of CD8A and CD8B) and zero CD4 count were labelled CD8+ T cells (1,130). Vice versa, T cells with zero CD8 and positive CD4 count were labelled CD4+ T cells (527). These were further split into Tregs if both their FOXP3 and CD25 (IL2RA) count was positive (64), and CD4+ Th cells otherwise (463). T cells that fulfilled neither the CD4+ nor the CD8+ criteria (411) contributed to the mixtures, but were not assessed by DTD. We augmented the reference matrix X, here consisting 3.5 Loss-function learning is beneficial even for small training sets, and the performance improves as the training dataset grows
We repeated the simulation in subsection 3.4, but varied the size of the training dataset. We observed that loss-function learning improved accuracy for training datasets as small as 15 samples. Moreover, with more training data added the boost in performance grew and saturated only for training sets with more than 1,000 samples (Figure 4 ).
3.6 HPC-empowered loss-function learning rediscovers established cell markers and complements them by new discriminatory genes for improved performance
Here, we introduce a final model, optimized on the 5,000 most variable genes. For this purpose, we generated 25,000 training mixtures from the melanomas of the training data. (3) and (6) with MPI, using the pbdMPI library (Chen et al. (2012b) , Chen et al. (2012a) ) as an interface. Furthermore, we linked R with the Intel Math Kernel Library for threaded and vectorized matrix operations. We ran the algorithm on 25 nodes of our QPACE 3 machine (Georg et al., 2017) with 8 MPI tasks per node and 32 hardware threads per task, where each thread can use two AVX512 vector units. In 16 hours 5,086 iterations were finished, after which the loss (3) was stable to within 1%.
The high-performance model includes several genes, whose expression is characteristic for the cells distinguished in the present study. These include, among others, the CD8A gene, which encodes an integral membrane glycoprotein essential for the activation of cytotoxic T-lymphocytes (Veillette et al., 1988) and the protection of a subset of NK cells against lysis, thus enabling them in contrast to CD8-NK cells to lyse multiple target cells (Addison et al., 2005) . As evident from Figure  5 , NK cells are clearly set apart from all the other cell types studied by the expression of the killer cell lectin like receptor genes KLRB1, KLRC1, and KLRF1 (Moretta et al., 2001 ). B cells, on the other hand, are clearly characterized by the expression of (i) CD19, which assembles with the antigen receptor of B lymphocytes and influences B-cell selection and differentiation (Rickert et al., 1995) , (ii) CD20 (MS4A1), which is coexpressed with CD19 and functions as a store-operated calcium channel (Li et al., 2003) , (iii) B Lymphocyte Kinase (BLK), a src-family protein tyrosine kinase that plays an important role in B-cell receptor signaling and phosphorylates specifically (iv) CD79A at Tyr-188 and Tyr-199 as well as CD79B (not among the top 150 genes) at , which are required for the surface expression and function of the B-cell antigen receptor complex (Hsueh and Scheuermann (2000) ), and (v) BLNK, which bridges BLK activation with downstream signaling pathways (Wienands et al., 1998) . The expression of FOXP3 is also highly cell specific. FOXP3 distinguishes regulatory T cells from other CD4+ cells and functions as a master regulator of their development and function (Hori et al. (2003) ). Finally, CD4+ T-helper (Th) cells are distinguished indirectly from all the other aforementioned lymphocytes by the lack of expression of cell type-specific genes. In contrast to lymphocytes, macrophages, cancer-associated fibroblasts (CAFs), and endothelial cells, which line the interior surface of blood vessels and lymphatic vessels, are characterized each by a much larger number of genes. Exemplary genes include CD14, CD163, MSR1, STAB1, and CSF1R for macrophages. The monocyte differentiation antigen CD14, for instance, mediates the innate immune response to bacterial lipopolysaccharide (LPS) by activating the NF-κB pathway and cytokine secretion (Haziot et al. (1996) ), while the colony stimulating factor 1 receptor (CSF1R) acts as a receptor for the hematopoietic growth factor CSF1, which controls the proliferation and function of macrophages (Sherr et al. (1985) ). CAFs, on the other hand, are distinguished by the expression of genes encoding extracellular matrix proteins such as fibulin-2 (FBLN2) and fibulin-3 (EFEMP1), various collagens (COL1A1, COL3A1, COL6A1, COL6A3), versican (VCAN), a well known mediator of cell-to-cell and cell-to-matrix interactions (Wu et al. (2005) ) that plays critical roles in cancer biology (Du et al. (2013) ), as well as the matrix metalloproteinases MMP1 and MMP2, two collagen degrading enzymes that allow cancer cells to migrate out of the primary tumor to form metastases (Gupta et al. (2014) ). Noteworthy is also GREM1, an antagonist of the bone morphogenetic protein pathway. Its expression and secretion by stromal cells in tumor tissues promotes the survival and proliferation of cancer cells (Sneddon et al., 2006) . Genes characteristic for endothelial cells include among others CDH5, a member of the cadherin superfamily essential for endothelial adherens junction assembly and maintenance (Gory-Faure et al. (1999) ), the endothelial cell-specific chemotaxis receptor (ECSCR) gene, which encodes a cell-surface single-transmembrane domain glycoprotein that plays a role in endothelial cell migration, apoptosis and proliferation (Shi et al. (2011) ), claudin-5 (CLDN5), which forms the backbone of tight junction strands between endothelial cells (Haseloff et al., 2015) , and the von Willebrand factor (VWF), which mediates the adhesion of platelets to sites of vascular damage by binding to specific platelet membrane glycoproteins and to constituents of exposed connective tissue (Sadler (1998) ).
We discussed 29 genes of the top 150 shown in Figure 5 . These genes have a total weight of 28% of all 5,000 gene weights (calculated asĝ i × var(X i,· )). Our algorithm complements this gene set with additional genes, including many that were, to our knowledge, not yet used to characterize cell types. An interesting example is CXorf36 (DIA1R), which has been described as being expressed at low levels in many tissues and deletion and/or mutations of which have been associated with autism spectrum disorders (Aziz et al., 2011) . However, nothing is known about its function to date. Therefore, its observed overexpression in endothelial cells may provide an important clue for future study on its function.
3.7 Loss-function learning shows similar performance as CIBERSORT for the dominating cell populations and improves accuracy for small populations and in the distinction of closely related cell types
Next we compared our model trained in subsection 3.6 to a competing method. For this, we generated 1,000 test mixtures from our validation melanomas. We chose CIBERSORT (Newman et al., 2015) for comparison, because it was consistently among the best DTD algorithm in a broad comparison of five different algorithms on several benchmark datasets (Newman et al., 2015) . We ran CIBERSORT on the test mixtures, using two distinct approaches: first, we uploaded our validation data to CIBERSORT using their reference profiles. The performance is summarized in Figure 6 as CIBERSORT a (yellow). We observed that the large population of B cells was estimated accurately, while smaller populations were inaccurate (NK cells, Tregs). Next, we uploaded our reference profiles and used the CIBERSORT gene selection (CIBERSORT b green). We found that highly abundant cell types (B cells and CD8+ T cells) were predicted with high accuracy. However, the distinction of similar cell types such as CD4+ T helper cells and Tregs was compromised, r = 0.42 and r = 0.42, respectively. Similarly, predictions for the small populations of CAFs were compromised. That might be explained by the fact that CIBERSORT does not take into account their distinction and thus appropriate marker genes might be missing. In a direct comparison to CIBERSORT our method showed similar or better performance.
Loss-function learning improves the decomposition of bulk melanoma profiles
All mixtures discussed so far were artificial because only 100 single-cell profiles were chosen randomly. They might differ significantly from mixtures in real tissue. Therefore, we generated 19 full bulk melanoma profiles by summing up the respective single-cell profiles. These should reflect bulk melanomas (Marinov et al., 2014) . Our predictions are contrasted with the true proportions in Figure 7 . Only the predictions for Tregs were compromised with r = 0.48, while the predictions FTL  SLA  CTSS  LYZ  CD8A  MS4A1  CD79A  CD19  BANK1  BLNK  BLK  LOC283663  KLRB1  IL2RB  B3GNT7  IPO11−LRRC70  KLRF1  KLRC1  NCR1  MATK  NCAM1  S1PR5  FOXP3  IL2RA  CD4  FCGR3A  TYROBP  C1QA  CD14  RNASE1  SPP1  TNFSF13  PLBD1  PLXDC2  FGL2  CLEC7A  APOC1  MS4A6A  AIF1  MS4A4A  F13A1  VSIG4  FCN1  MSR1  FOLR2  CSF1R  IGSF6  RNASE2  SLC31A2  TREM2  CD163  IL4I1  TLR2  HAMP  CXCL11  CCL21  IGFBP7  CYR61  EFEMP1  C3  CXCL12  AXL  VCAN  TGFBI  DCN  COL1A1  COL3A1  H19  LPAR1  ADH1B  MEG3  CRISPLD2  HSD11B1  CYBRD1  PI16  KRT19  GREM1  MXRA8  RARRES1  FGF7  ISLR  CD248  COL6A3  DKK1  GGT5  C10orf10  RARRES2  C1R  C7  CLDN11  MMP2  MMP1  MFAP4  POSTN  CFB  CFH  ABI3BP  CDH11  COL6A1  LOX  ADAMTS1  C12orf75  CRIP2  NPDC1  ECE1  STAB1  TSPAN15  EGFL7  LYVE1  CCL2  ENG  ALDH2  C1orf54  PLAUR  RASGRP3  PECAM1  ELK3  CLDN5  CCL14  FABP4  MIR941−3  ECSCR  VWF  MIR3654  MMRN1  CXorf36  CCBP2  CALCRL  KDR  MYCT1  GJA4  TFF3  CDH5  SULF2  HSD3B7  PPAP2B  SERPINE1  PROCR  ID1  SPARCL1  TFPI  TSPAN7  HYAL2  RAI14  CD34  GJA1  COL4A1  RHOJ  RAMP3 for all other cell types were reliable with correlations ranging from r = 0.70 (CD4+ Th) to r = 0.99 (CAFs) on the validation melanomas.
Discussion
We suggest loss-function learning for digital tissue deconvolution to adapt the deconvolution algorithm to the requirements of specific application domains. The concept is similar to an embedded feature-selection approach in regression or classification problems. In both contexts feature selection is directly linked to a prediction algorithm and not treated as an independent preprocessing step.
We described and tested a specific instance of loss-function learning using squared residuals for L g . The concept is not limited to this type of inner loss function and can also be used in combination with other loss functions such as those from penalized least-squares regression (Altboum et al., 2014), l 1 regression, or support vector regression (Newman et al., 2015) . However, the leastsquares loss function allowed us to state the outer optimization problem in a closed analytical form, reducing computational burden. The outer loss function L evaluates the fit of estimated and true cellular proportions in the training samples. We chose the correlation of estimated versus true quantities across samples, and no absolute measure of deviation such as ||c −ĉ|| 2 2 . Moreover, we did not require the estimated proportionsĈ ·,k for tissue k to sum up to one. Consequently, when testing our method we did not look at absolute deviations of true versus estimated cell proportions but only at their correlation. We cannot reliably infer how many cells of a specific type (e.g., T cells) are in a tissue (Figure 7) , nor can we infer whether they constituted 10% or 20% of the cells in this tissue. However, if we had two tissues and estimated that there were more cells of that type in the first tissue compared to the second, this relation was also found in the true cell populations. Calibrating the method to absolute cell numbers or percentages within a tissue appears to be difficult. This might be due to the normalization of the libraries from single cells to a common size, which might not reflect true biology if, for example, some cell types contain more RNA than others. Post-hoc normalization of the estimated quantities might be an option.
In summary, we introduced loss-function learning as a new machine-learning approach to the digital tissue deconvolution problem. It allows us to adapt to application-specific requirements such as focusing on small cell populations or delineating similar cell types. In simulations and in an application to melanoma tissues our method quantified large cell fractions as accurately as existing methods and significantly improved the detection of small cell populations and the distinction of similar cell types.
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